Vaxcyte Q3 EPS $(1.99) Beats $(2.12) Estimate
Benzinga Newsdesk 6 hours ago
NewsEarningsEarnings Beats
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.12) by 6.13 percent. This is a 27.56 percent decrease over losses of $(1.56) per share from the same
Vaxcyte (NASDAQ:PCVX) reported quarterly losses of $(1.99) per share which beat the analyst consensus estimate of $(2.12) by 6.13 percent. This is a 27.56 percent decrease over losses of $(1.56) per share from the same period last year.